News

Discover how entrepreneurs and non-technical teams are using AI tools to instantly turn ideas into working apps through vibe coding.
Vibe coding is back at the forefront of the AI coding discussion thanks to new tools from Open AI and Anthropic, but what do ...
Ask the publishers to restore access to 500,000+ books. The Internet Archive keeps the record straight by preserving government websites, news publications, historical documents, and more. If you find ...
This is a potentially valuable modeling study on sequence generation in the hippocampus in a variety of behavioral contexts. While the scope of the model is ambitious, its presentation is incomplete ...
The Colosseum Project has a JORC-2012 compliant Mineral Resource of 27.1 million tons at 1.26 g/t gold, totaling 1.1 million ounces, with 455,000 ounces classified as Measured, 281,000 ounces as ...
NEW YORK and BERLIN and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a ...
today announced the successful delivery of its sixth Sentinel Fixed-Gantry CT system under a $3.5 million contract awarded by a major North American nuclear energy client. The Company believes ...
OWSLib provides a common API for accessing service metadata and wrappers for numerous OGC Web Service interfaces. A very similar API exists for WebFeatureService. See ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating zocilurtatug pelitecan, or ZL-1310, the Company ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring (TRM), a liquid ...
Kombu is a messaging library for Python. The aim of Kombu is to make messaging in Python ... Disabled by default, but can be enabled by using the supports_fanout transport option. [3] AMQP Message ...
Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented today at the 2025 American ...